Journey Medical Corp. (DERM)
6.14
-0.18
(-2.85%)
USD |
NASDAQ |
Sep 25, 16:00
6.14
0.00 (0.00%)
After-Hours: 19:08
Journey Medical Cash from Operations (TTM) : -7.567M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.567M |
| March 31, 2026 | -6.775M |
| December 31, 2025 | -12.52M |
| September 30, 2025 | -3.932M |
| June 30, 2025 | -2.706M |
| March 31, 2025 | -6.94M |
| December 31, 2024 | -9.127M |
| September 30, 2024 | -27.78M |
| June 30, 2024 | -7.877M |
| Date | Value |
|---|---|
| March 31, 2024 | 1.177M |
| December 31, 2023 | 5.24M |
| September 30, 2023 | 17.83M |
| June 30, 2023 | -8.196M |
| March 31, 2023 | -15.37M |
| December 31, 2022 | -13.53M |
| September 30, 2022 | -12.90M |
| June 30, 2022 | 1.48M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Nektar Therapeutics | -233.79M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 27.61B |